In 496 brain-dead kidney donors (643 recipients analysed), cyclosporine pretreatment did not reduce delayed graft function versus placebo (17.0% vs 13.9%; OR 1.27, P=0.28); early graft function and 1-year graft and recipient survival also did not differ.
RCTn = 643 recipients
Ichai et al. Cyclosporine versus placebo pretreatment of brain-dead donors and kidney graft function (Cis-A-Rein trial): a multicenter, double-blind, randomized, controlled trial